BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...Venture Partnership, Hangzhou Real Asset Management Fund, Fang Fund Partners and Chengdu Beiduojian. Existing investors Sangel Capital...
...LLC CG Oncology, Inc. Kissei Pharmaceutical Co. Ltd. ORI Healthcare Fund Perseverance Capital Management Denovo Biopharma LLC CICC Qide Yingke PE China Resources Pharmaceutical Sangel Capital Zheshang...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...series A round led by Korea Investment Partners with participation by Topping Capital, TigerYeah Capital, Sangel Capital...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Lu, has STP705 in Phase II testing for non-melanoma skin cancer and hypertrophic scar reduction. Sangel Capital...
...Investment, and Lanshang Capital and previous investors Lucion Venture Capital, Shandong Transportation Development Fund and Sangel Capital...
BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

...CICC Qide Fund, with participation by existing investors Jiuyou Capital, Share Capital, CITIC Securities and Sangel Capital...
BioCentury | Dec 26, 2019
Company News

Dec. 27 Company Quick Takes: Immunomedics, Qiagen, Eisai-Gilead, Melinta, Denovo-Rumpus

...payment and is eligible for $100 million in milestones, plus royalties, according to Denovo investor Sangel Capital...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...2016 KBP BioSciences Co. Ltd. Jinan, China $76.0 Advantech Capital , SDIC Venture Capital , Sangel Capital...
BioCentury | Feb 21, 2019
Emerging Company Profile

Refuge: Receptive CAR checkpoints

...million Investors: 3SBio Inc., Sequoia China, 3E Bioventures, WuXi Healthcare Ventures, ShangBay Capital, Danhua Capital, Sangel Capital...
BioCentury | May 4, 2018
Financial News

Refuge raises $25M series B

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...
BioCentury | May 2, 2018
Financial News

Refuge raises $25M series B

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...round on Jan. 5 co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital...
Items per page:
1 - 10 of 11
BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...Venture Partnership, Hangzhou Real Asset Management Fund, Fang Fund Partners and Chengdu Beiduojian. Existing investors Sangel Capital...
...LLC CG Oncology, Inc. Kissei Pharmaceutical Co. Ltd. ORI Healthcare Fund Perseverance Capital Management Denovo Biopharma LLC CICC Qide Yingke PE China Resources Pharmaceutical Sangel Capital Zheshang...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...series A round led by Korea Investment Partners with participation by Topping Capital, TigerYeah Capital, Sangel Capital...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Lu, has STP705 in Phase II testing for non-melanoma skin cancer and hypertrophic scar reduction. Sangel Capital...
...Investment, and Lanshang Capital and previous investors Lucion Venture Capital, Shandong Transportation Development Fund and Sangel Capital...
BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

...CICC Qide Fund, with participation by existing investors Jiuyou Capital, Share Capital, CITIC Securities and Sangel Capital...
BioCentury | Dec 26, 2019
Company News

Dec. 27 Company Quick Takes: Immunomedics, Qiagen, Eisai-Gilead, Melinta, Denovo-Rumpus

...payment and is eligible for $100 million in milestones, plus royalties, according to Denovo investor Sangel Capital...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...2016 KBP BioSciences Co. Ltd. Jinan, China $76.0 Advantech Capital , SDIC Venture Capital , Sangel Capital...
BioCentury | Feb 21, 2019
Emerging Company Profile

Refuge: Receptive CAR checkpoints

...million Investors: 3SBio Inc., Sequoia China, 3E Bioventures, WuXi Healthcare Ventures, ShangBay Capital, Danhua Capital, Sangel Capital...
BioCentury | May 4, 2018
Financial News

Refuge raises $25M series B

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...
BioCentury | May 2, 2018
Financial News

Refuge raises $25M series B

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...round on Jan. 5 co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital...
Items per page:
1 - 10 of 11